Long-term rapamycin therapy in the Han:SPRD rat model of polycystic kidney disease (PKD). (Q43069328)

13 November 2017

Long-term rapamycin therapy in the Han:SPRD rat model of polycystic kidney disease (PKD). (English)

1 reference

polycystic kidney disease

13 November 2017

1 reference

1 reference

Iram Zafar

1

1 reference

13 November 2017

Franck A Belibi

series ordinal

2

1 reference

13 November 2017

Zhibin He

series ordinal

3

1 reference

13 November 2017

Charles L Edelstein

series ordinal

4

1 reference

13 November 2017

language of work or name

English

0 references

publication date

25 March 2009

1 reference

Nephrology Dialysis Transplantation

13 November 2017

1 reference

13 November 2017

24

1 reference

13 November 2017

2349-2353

1 reference

13 November 2017

8

1 reference

The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease

13 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727300

Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727300

Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727300

Hypertension in autosomal-dominant polycystic kidney disease: early occurrence and unique aspects

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727300

Targeting of the rasT24 oncogene to the proximal convoluted tubules in transgenic mice results in hyperplasia and polycystic kidneys

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727300

The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727300

Mitogen-activated 70K S6 kinase. Identification of in vitro 40 S ribosomal S6 phosphorylation sites

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727300

c-myc as an inducer of polycystic kidney disease in transgenic mice

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727300

Effect of sirolimus on left ventricular hypertrophy in kidney transplant recipients: a 1-year nonrandomized controlled trial

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727300

Effect of statin and angiotensin-converting enzyme inhibition on structural and hemodynamic alterations in autosomal dominant polycystic kidney disease model.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727300

Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727300

Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727300

Rapamycin attenuates load-induced cardiac hypertrophy in mice

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727300

Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease: a longitudinal study.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727300

Gender and the effect of gonadal hormones on the progression of inherited polycystic kidney disease in rats.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2727300

Occipital glucose metabolism in dementia with lewy bodies with and without Parkinsonism: a study using positron emission tomography

15 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FNDT%2FGFP129

Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease

21 January 2018

1 reference

12 December 2020

Everolimus retards cyst growth and preserves kidney function in a rodent model for polycystic kidney disease

1 reference

12 December 2020

Hypertension and renal injury in experimental polycystic kidney disease

1 reference

12 December 2020

Downregulation of the calpain inhibitor protein calpastatin by caspases during renal ischemia-reperfusion

1 reference

12 December 2020

Polycystic kidney disease

1 reference

12 December 2020

Substrate recognition determinants of the mitogen-activated 70K S6 kinase from rat liver

1 reference

12 December 2020

Autosomal-dominant polycystic kidney disease in the rat

1 reference

12 December 2020

Autosomal dominant polycystic kidney disease

1 reference

12 December 2020

Characterization of the Han:SPRD rat model for hereditary polycystic kidney disease

1 reference

12 December 2020

Identifiers

DOI

10.1093/NDT/GFP129

1 reference

13 November 2017

1 reference

13 November 2017

1 reference